Lactobacillus Rhamnosus LRa05

N/A

Report date: 2024/01/10 17:54:27

Base Information

Drug NameLactobacillus Rhamnosus LRa05
Drug Alias NameLactobacillus Rhamnose LRa05鼠李糖乳酪杆菌LRa05probiotic LRa05鼠李糖乳杆菌LRa05Lacticaseibacillus rhamnosus LRa05 +[10] 
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsHelicobacter pylori infectionDiarrheaDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Women And Children'S Central HospitalThe First Affiliated Hospital Of Harbin Medical UniversityJiangsu Weikang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infectionDiarrheaDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A